outstanding speakers in every program
successfull previous programs
senior executives who are graduates of the program
2015/12/14 08:00:00
until next program




This unique intensive four-day program focuses on the critical elements in the formation, launch, and strategic and operational management of health-related technologies, with a particular focus on companies developing and enabling technologies in biotechnology, medical devices and healthcare IT.

The program is conducted by top-tier faculty members who are high-ranking executives at successful global medical device and bio-pharmaceutical companies, as well as accomplished venture capitalists, regulators, attorneys, entrepreneurs and academics from leading US and worldwide healthcare firms. It is one of only a handful of such programs in the world that brings together leaders from emerging, high potential companies and talented, experienced faculty.



The program aims to attract Israeli and international individuals with an outstanding potential for leadership in the healthcare sector who occupy positions that require a deep understanding of how healthcare innovations can be commercialized.This is a target group that includes entrepreneurs and executives in the pharmaceutical, biotechnology, medical device , health IT and digital health industries.

  • Lessons learned from our experience and practical tips: A panel of life science CEOs and entrepreneurs (Israeli and US)
  • Market analysis and competitive analysis: Essentials of marketing in biotechnology and medical devices
  • Capitalization of a life science venture (this session includes issues concerning the value inflection points, alternative financing etc.)
  • Designing and conducting clinical trials: From proof of concept to marketing success (including demonstrating quality and value for consumers for reimbursement success)
  • Intellectual capital management
  • Incorporating reimbursement into the company development strategy
  • Biopharmaceutical and medical device licensing, partnering and strategic alliances
  • Emerging markets: Opportunities for life science companies
  • Personalized medicine
  • The persuasive pitch
  • Healthcare IT and digital health
  • Case studies
  • Several keynote lectures

* Please note that this is a preliminary list of topics and is subject to change.


  •  Good networking opportunity. A very informative overview of the industry. Exposure to very experienced leading figures.

    Simon Robinson
    CEO, Stepwise Ltd.
  • This program provides very good insight into the long and exciting process associated with the development of products, technologies and companies in the medical domain. I enjoyed the program very much and more importantly, learned a lot.

    Shmuel Shmueli
    CEO, Bayonet Nano-Tech (NanoThera)
  • I found the program most helpful and interesting, it definitely widened my point of view, and supplied tools for better management. I would like to point out the quality of the faculty and participants. Thank you.

    Shahar Millis
    CEO, Fidmi Medical
  • The seminar was well built. The whole aspect of medical device industry from A to Z were covered. Experienced people with relevant stories were brought in, review of people really involved and understanding the matter. On top of it really assigned to help and support the people on the program. Thank you.

    Amir Gilead
    CEO, Flow-Med
  • Everything was wonderful and well organized, it was a pleasure! Thank you.



    Shlomi Toussia-Cohen
    Business development & analyst, Rad Biomed Accelerator
  • There is not one CEO that I am aware of that has loop understanding in all aspects of the business. It was refreshing to get these fascinating presentations, covers almost all areas of running a company. I must admit that I was surprised as I experienced greater time than I expected and obviously expanded my knowledge while escalating networking. Well done!
    I must admit that I was surprised as I experienced greater time than I expected and obviously expanded my knowledge while escalating networking.

    Erez Rozenfeld
    CEO, V Wave
  • I want to say what an interesting course you run.  In my experience, there is only one moderately comparable “boot camp” for life sciences – largely biotech companies – and that occurs on the day before the BIO annual meeting in the US.  It is “generic” (dealing with a multitude of nationalities and levels of management) although some of the courses on negotiation and contracting are very good.  What is stunningly advantageous about your course is the fact that it has a national focus. As a consequence the effect of cross-pollination of ideas and interactions – such a valuable aspect of the course – is likely to be magnified.

    I would be thrilled to participate if invited again.  And spend more time at the course.

    Jeremy Levin
    Jeremy Levin
  • The program extended manager’s tools and improves their general skills. It opened our mind to different ideas and global understanding of the medical device arena, and Improved personal relationships with the industry and faculty. Thank you.

    Yehuda Zadok
    CEO, Rainbow Medical